These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4479350)

  • 21. Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin.
    Ohnhaus EE; Kirchhof B; Peheim E
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):591-7. PubMed ID: 35298
    [No Abstract]   [Full Text] [Related]  

  • 22. Aflatoxin B 1 and phenobarbital inducible aflatoxin- 2 -hydration by rat liver microsomes.
    Schabort JC; Steyn M
    Biochem Pharmacol; 1972 Nov; 21(21):2931-3. PubMed ID: 4646811
    [No Abstract]   [Full Text] [Related]  

  • 23. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM; Teunissen MW; Breimer DD
    Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of serum antipyrine half-lives in patients with liver disease.
    Branch RA; Herbert CM; Read AE
    Gut; 1973 Jul; 14(7):569-73. PubMed ID: 4729926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-dependent enzyme induction.
    Breckenridge A; Orme ML; Davies L; Thorgeirsson SS; Davies DS
    Clin Pharmacol Ther; 1973; 14(4):514-20. PubMed ID: 4723259
    [No Abstract]   [Full Text] [Related]  

  • 26. The plasma half-life of antipyrine in chromic uraemic and normal subjects.
    Maddocks JL; Wake CJ; Harber MJ
    Br J Clin Pharmacol; 1975 Aug; 2(4):339-43. PubMed ID: 1233993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A re-evaluation of intersubject variation in enzyme induction in man.
    Branch RA; Shand DG
    Clin Pharmacokinet; 1979; 4(2):104-10. PubMed ID: 455871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioimpedance assessment of antipyrine pharmacokinetics before and after enzyme induction.
    Pilla AM; Zarowitz BJ; Svensson CK; Peterson EL; Popovich J
    DICP; 1990 Jun; 24(6):575-80. PubMed ID: 2360333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation between drug-metabolizing activity and phospholipids in hepatic microsomes. I. Effects of phenobarbital, carbon tetrachloride, and actinomycin D.
    Cooper SD; Feuer G
    Can J Physiol Pharmacol; 1972 Jun; 50(6):568-75. PubMed ID: 4340131
    [No Abstract]   [Full Text] [Related]  

  • 30. Oxidative metabolism of carbon disulphide by the rat. Effect of treatments which modify the liver toxicity of carbon disulphide.
    De Matteis F; Seawright AA
    Chem Biol Interact; 1973 Dec; 7(6):375-88. PubMed ID: 4150011
    [No Abstract]   [Full Text] [Related]  

  • 31. Immediate decrease by hydrocortisone of the plasma half-life of antipyrine.
    Breckenridge A; Burke CW; Davies DS; Orme ML
    Br J Pharmacol; 1973 Feb; 47(2):434-6. PubMed ID: 4722054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidation of 5 beta-cholestane-3alpha, 7alpha, 12alpha-triol by rat liver microsomes.
    Cronholm T; Johansson G
    Eur J Biochem; 1970 Oct; 16(2):373-81. PubMed ID: 4394310
    [No Abstract]   [Full Text] [Related]  

  • 33. [Inhibition of drug hydroxylation in vivo by ethanol loading].
    Schüppel R
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 265(2):156-69. PubMed ID: 4243214
    [No Abstract]   [Full Text] [Related]  

  • 34. Antipyrine plasma half-life. In vivo indicator of oxidative metabolic capability in Rhesus monkeys (Macaca mulatta).
    Miller JL; Clark CR; Gee SJ; Krieger RI
    Pharmacology; 1978; 16(5):279-86. PubMed ID: 417345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipyrine metabolite kinetics in phenobarbital and beta-naphthoflavone-induced rats.
    Rhodes JC; Houston JB
    Drug Metab Dispos; 1983; 11(2):131-6. PubMed ID: 6133717
    [No Abstract]   [Full Text] [Related]  

  • 36. N-ethylmaleimide adduct of 7,12-dimethylbenzanthracene. Properties and metabolism by rat liver microsomes.
    Jellinck PH; Smith G
    Biochem Pharmacol; 1972 Jun; 21(11):1603-8. PubMed ID: 4119045
    [No Abstract]   [Full Text] [Related]  

  • 37. Ranitidine alters antipyrine metabolism in control and phenobarbital-treated mice.
    Espiritu-Quiza MF; Skinner MH; Blaschke TF
    Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):631-6. PubMed ID: 2084458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme induction by phenobarbitone and vitamin K1 disposition in man.
    Park BK; Wilson AC; Kaatz G; Ohnhaus EE
    Br J Clin Pharmacol; 1984 Jul; 18(1):94-7. PubMed ID: 6743493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study on the effects of ibuprofen on the metabolism of antipyrine in man.
    Lee P; Bell MA; Webb J; Goh V; Chalmers IM
    Med J Aust; 1973 Nov; 2(18):846-9. PubMed ID: 4205721
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction of hepatic microsomal enzymes after brief administration of rifampicin in man.
    Miguet JP; Mavier P; Soussy CJ; Dhumeaux D
    Gastroenterology; 1977 May; 72(5 Pt 1):924-6. PubMed ID: 849823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.